§ 20-617 — (Formerly Sec. 20-184e). Prescriptions: Notation of drug quantity, expiration date, generic name and drug manufacturer and MedWatch program information. Label information for generic drug substitutions.

(a) Each pharmacist shall include on the label of each prescription container: (1) The quantity of prescribed drug placed in such container, in addition to any other information required by law, and (2) a prominently printed expiration date based on the manufacturer's recommended conditions of use and storage that can be read and understood by the ordinary individual. The expiration date required pursuant to subdivision (2) of this subsection shall be no later than the expiration date determined by the manufacturer. (b) In addition to the information required to be included on the label of each prescription container pursuant to subsections (a) and (c) of this section, each pharmacist shall include on the label of each prescription container or on the receipt or other similar packaging in which the prescription is contained for a drug sold only by generic name, as defined in section 20-14a , and not by brand name, as defined in said section: (1) The name of the manufacturer of the generic drug placed in the container, and (2) the Internet web site address and toll-free telephone number for the United States Food and Drug Administration's safety information and adverse event reporting program (MedWatch). (c) In addition to the information required to be included on the label of each prescription container pursuant to subsections (a) and (b) of this section, if a pharmacist substitutes a generic name drug for a brand name drug, such pharmacist shall include on the label of the prescription container: (1) The name of the generic drug placed in the container, and (2) the brand name of the drug that the generic drug was substituted for.

Legislative History

(P.A. 93-94; P.A. 99-49; 99-175, S. 38; P.A. 00-182, S. 3; P.A. 15-219, S. 1.) History: Sec. 20-184e transferred to Sec. 20-617 in 1997; P.A. 99-49 made a technical change, added Subdiv. indicators and added provision requiring prescription drug container label to include drug's expiration date; P.A. 99-175 made technical changes and deleted reference to Sec. 20-590; P.A. 00-182 added language re manufacturer's recommended conditions of use and storage and deleted language re customary conditions of purchase, and use and storage and re absence of contrary data; P.A. 15-219 designated existing provisions as Subsec. (a), added Subsec. (b) re inclusion on label of name of manufacturer of generic drug and MedWatch program information, added Subsec. (c) re required label information for generic substitutes, and made technical changes, effective January 1, 2016.